DTGCX
Price
$38.39
Change
+$0.26 (+0.68%)
Updated
Jun 12 closing price
Net Assets
567.66M
PRGTX
Price
$35.88
Change
+$0.35 (+0.99%)
Updated
Jun 12 closing price
Net Assets
8.15B
Interact to see
Advertisement

DTGCX vs PRGTX

Header iconDTGCX vs PRGTX Comparison
Open Charts DTGCX vs PRGTXBanner chart's image
DTGCX vs PRGTX Comparison Chart in %
View a ticker or compare two or three
VS
DTGCX vs. PRGTX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTGCX is a Hold and PRGTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 8.15B vs. DTGCX (568M). DTGCX (0.00) and PRGTX (0.00) have matching dividends . DTGCX was incepted earlier than PRGTX: DTGCX (27 years) vs PRGTX (26 years). DTGCX (1.97) is less costly to investors than PRGTX (0.93). PRGTX (34.60) and DTGCX (33.84) have comparable annual turnover. DTGCX has a lower initial minimum investment than PRGTX: DTGCX (1000) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 65.04 vs. DTGCX (17.65). PRGTX return over 5 years is better than : 20.81 vs. DTGCX (-6.93).
DTGCXPRGTXDTGCX / PRGTX
Total Expense Ratio1.970.93212%
Annual Report Gross Expense Ratio1.970.93212%
Fund Existence27 years26 years-
Gain YTD27.88135.14179%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets568M8.15B7%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.6565.0427%
Returns for 3 years65.90151.6143%
Returns for 5 years-6.9320.81-33%
Returns for 10 years16.76164.4110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEN6.79N/A
N/A
Wendy's Company
OACC10.66N/A
N/A
Oaktree Acquisition Corp. III Life Sciences
BLIV2.39N/A
N/A
BeLive Holdings
VRTX444.92-0.12
-0.03%
Vertex Pharmaceuticals
MIRM99.35-0.20
-0.20%
Mirum Pharmaceuticals